Rhabdomyolysis due to interaction of simvastatin with mibefradil

The complex polyploid genome architecture of sugarcane.

Nature·2024

Assessing the perspective of well-being of older patients with multiple morbidities by using the LAVA tool - a person-centered approach.

BMC geriatrics·2021

Multicenter Evaluation of the Clinical Performance and the Neutralizing Antibody Activity Prediction Properties of 10 High-Throughput Serological Assays Used in Clinical Laboratories.

Journal of clinical microbiology·2020

[Epidemiology and prevention of heat-related adverse health effects on elderly people].

Zeitschrift fur Gerontologie und Geriatrie·2019

Association of generalized anxiety symptoms and panic with health care costs in older age-Results from the ESTHER cohort study.

Journal of affective disorders·2018

The NTCP-inhibitor Myrcludex B: Effects on Bile Acid Disposition and Tenofovir Pharmacokinetics.

Clinical pharmacology and therapeutics·2017

8 weeks versus 12 weeks of sofosbuvir-velpatasvir for treatment-naive, non-cirrhotic, chronic hepatitis C (RESOLVE): a multicentre, open-label, non-inferiority, randomised controlled trial in India.

Lancet (London, England)·2026

Cardiovascular safety of orforglipron versus insulin glargine in adults with type 2 diabetes at increased cardiovascular risk (ACHIEVE-4): a phase 3, event-driven, randomised, open-label, non-inferiority, active comparator trial.

Lancet (London, England)·2026

A trembling detour to the diagnosis of encephalitis: a neuroborreliosis case report.

Lancet (London, England)·2026

Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial.

Lancet (London, England)·2026

Efficacy and safety of garetosmab, an activin A-blocking antibody, in fibrodysplasia ossificans progressiva (OPTIMA): a randomised, double-blind, placebo-controlled, phase 3 trial.

Lancet (London, England)·2026

Radiotherapy versus observation following surgical resection of WHO grade 2 atypical meningioma (ROAM/EORTC-1308): an international, multicentre, open-label, phase 3, randomised controlled trial.

Lancet (London, England)·2026

Timely evidence generation in epidemic response: lessons from an attempted analytical epidemiological investigation during an mpox outbreak, Ireland, 2022.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2026

Microbiological profiles of Gram-negative bacteria isolated from respiratory samples of mechanically ventilated patients at a tertiary Moroccan hospital.

IJID regions·2026

Long-Term Survival Following Nivolumab Treatment in Pulmonary Tumour Thrombotic Microangiopathy Associated With Cancer of Unknown Primary: A Case Report.

Respirology case reports·2026

Clinical, cytogenetic, and molecular insights from 32 years of the Portuguese Fanconi anemia cohort.

Genetics in medicine open·2026

Vancomycin-induced immune hemolytic anemia: a case report and literature review.

Frontiers in immunology·2026

Structured Histopathology Distinguishes AFRS From eCRSwNP.

The Laryngoscope·2026

Related Experiment Videos

Rhabdomyolysis due to interaction of simvastatin with mibefradil

Related Concept Videos

The complex polyploid genome architecture of sugarcane.

Assessing the perspective of well-being of older patients with multiple morbidities by using the LAVA tool - a person-centered approach.

Multicenter Evaluation of the Clinical Performance and the Neutralizing Antibody Activity Prediction Properties of 10 High-Throughput Serological Assays Used in Clinical Laboratories.

[Epidemiology and prevention of heat-related adverse health effects on elderly people].

Association of generalized anxiety symptoms and panic with health care costs in older age-Results from the ESTHER cohort study.

The NTCP-inhibitor Myrcludex B: Effects on Bile Acid Disposition and Tenofovir Pharmacokinetics.

8 weeks versus 12 weeks of sofosbuvir-velpatasvir for treatment-naive, non-cirrhotic, chronic hepatitis C (RESOLVE): a multicentre, open-label, non-inferiority, randomised controlled trial in India.

Cardiovascular safety of orforglipron versus insulin glargine in adults with type 2 diabetes at increased cardiovascular risk (ACHIEVE-4): a phase 3, event-driven, randomised, open-label, non-inferiority, active comparator trial.

A trembling detour to the diagnosis of encephalitis: a neuroborreliosis case report.

Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial.

Efficacy and safety of garetosmab, an activin A-blocking antibody, in fibrodysplasia ossificans progressiva (OPTIMA): a randomised, double-blind, placebo-controlled, phase 3 trial.

Radiotherapy versus observation following surgical resection of WHO grade 2 atypical meningioma (ROAM/EORTC-1308): an international, multicentre, open-label, phase 3, randomised controlled trial.

Timely evidence generation in epidemic response: lessons from an attempted analytical epidemiological investigation during an mpox outbreak, Ireland, 2022.

Microbiological profiles of Gram-negative bacteria isolated from respiratory samples of mechanically ventilated patients at a tertiary Moroccan hospital.

Long-Term Survival Following Nivolumab Treatment in Pulmonary Tumour Thrombotic Microangiopathy Associated With Cancer of Unknown Primary: A Case Report.

Clinical, cytogenetic, and molecular insights from 32 years of the Portuguese Fanconi anemia cohort.

Vancomycin-induced immune hemolytic anemia: a case report and literature review.

Structured Histopathology Distinguishes AFRS From eCRSwNP.

Related Experiment Videos

Rhabdomyolysis due to interaction of simvastatin with mibefradil

Related Concept Videos

Related Articles